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DNA Adducts in Human Urinary Bladder
and Other Tissues
by David H. PhillipsI and Alan Hewer'
Tobacco smoking is associated with an inaeased risk ofcancer in a number oforgans, including bladder and lung. Tobac-
co smoke contains at least 50 known chemical carcinogens that exert their biological effects through their covalent bind-
ing to cellular DNA. Examining human DNA for the presence of altered nucleotides is a means of monitoring exposure
to genotoxic chemicals. DNA isolated from 73 human bladder biopsies has been analyzed by 32P-postlabelingforthe presence
ofaromatic/hydrophobic adducts. Butanol eation ofDNA digests resulted in up to a 3-fold greater recovery ofadducts
than nuclease PI digestion. Among 16 nonsmokers, adduct levels were in the range 3.2-208/10' nucleotides (mean 9.7).
Eight ex-smokers had values in the range 2.-12.3 (mean 7.1). Thirteen smokers had adduct levels between 1.3 and 26.7
adducts/lO' nucleotides (mean 9.5, not different from nonsmokers). Six cigar smokers had higher levels ofadducts (mean
12.1, range 7.3-15.0), but pipe smokers did not (five samples, mean 86, range 2.9-12.7). A further 8 samples from
nonsmokers and 17 from smokers were examind in more detail. Although most oftheDNA binding appears not to be smok-
ing related, the levels ofone adduct were found to be on average 2-fold higher in smokers p<O.005, one-tailed ttest). Studies
on tissues ofthe respiratory tract demonstate a correlation between DNAadduct levels and exposure to tobacco smoke.
Evidence to date on the influence ofsmoking on adducts in peripheral blood cells is equivocal; some studies demonstrate
a significant effect, whereas others do not. It is probable that the effect of smoking on adduct formation on blood cells
is a weak one and that other undetermined exposures have greater influence.
Introduction
The risk to human health of cigarette smoking has been exten-
sively studied and documented. Although the major site of
cancer induction by tobacco smoke is the lung, smoking is also
an important cause ofbladder cancer in humans (1). In countries
in which tobacco smoking is a widespread and long-standing
habit, around half of all cases of bladder cancer in men, and
around a quarter ofcases in women, are attributable to cigarette
smoking. Pipe and cigar smoking probably also constitute an in-
crease to the risk of developing bladder cancer, but at a lower
level of risk than that associated with cigarette smoking.
Tobacco smoke is a complex mixture of several thousand iden-
tified chemicals, including more than 50 that are carcinogenic to
experimental animals. Three major classes of carcinogens that
are found are nitrosamines, polycyclic aromatic hydrocarbons
(PAHs), and aromatic amines. DNA adducts formed by the lat-
ter two classes can be readily detected by 32P-postlabeling
analysis (2). Two variations on the procedure that dramatically
enhance its sensitivity can be applied to the detection of some
classes ofadducts: the butanol extraction method will detect ad-
ducts formed by PAHs and aromatic amines, whereas the
nuclease P, digestion procedure detects PAH-DNA adducts, but
not, under some conditions, those formed by aromatic amines
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(3,4). Thus, comparative use of these procedures can reveal
qualitative information about the nature of adducts detected in
human tissues.
In this paper we describe results ofexperiments to investigate
the influence of tobacco smoking on the levels ofDNA adducts
in human urinary bladder epithelium and compare these findings
with results of studies ofother human tissues, notably cells ofthe
respiratory tract and circulating blood cells.
Materials and Methods
Biopsy samples ofbladder epithelium were taken from 73 in-
dividuals undergoing cystoscopic examinations. The samples
were frozen and stored at -75 °C before, DNA isolation. DNA
was isolated by a solvent extraction procedure adapted for small
tissue samples, as described by Schoket et al. (5).
DNA samples (4 tsg) were digested enzymically to 3 '-
monophosphates with micrococcal nuclease and spleen
phosphodiesterase (2) and then either further digested with
nuclease P1 (6) or extracted with butanol (7). TheDNA digests
or the residues of the butanol extracts were then 32P-labeled by
incubation with carrier-free [Ly-32P]ATP (50 ,uCi, 1.85 MBq) and
T4 polynucleotide kinase, and the reaction terminated by the ad-
dition of potato apyrase (3). Resolution of the labeled adducts
was then carried out on polyethyleneimine-cellulose (PEI-
cellulose) TLC sheets using the solvents used in earlier studies
(8): DI, 1 M sodium phosphate, pH 6.0, on to a filter-paper wick;
D2 (opposite to DI), 3.5M lithium formate, 8.5M urea, pH 3.5;
D3 (at 900 to D2), 0.8M LiCl, 0.5M Tris-HCl, 8.5M urea, pH





FIGURE 1. Examples ofautoradiographs ofPEI-cellulose chromatograms of 32P-postlabeled adducts in human bladder DNA. (a) Butanol-extraction-enhanced label-
ing ofDNA from a 71-year-old male smoker (10 cigarettes/day); (b) butanol-extniction-enhanced labeling ofDNA from a 91-year-old female nonsmoker; (c) nuclease
Pi-enhanced labeling ofDNA from a 69-year-old male smoker (20 cigarettes/day); (a) nuclease P,-enhanced labeling ofDNA from a 66-year-old female nonsmoker.
Adduct 5 (butanol extraction) is indicated by an arrow.
on to a filter-paper wick. Adducts were detected by autoradi-
ography and quantitated by Cerenkov counting ofthe appropriate
areas of the chromatograms.
DNA Adducts in Human Urinary
Bladder
Samples from48 indviduals were analyzed by 32P-postlabeling
using the butanol extraction and nuclease PI digestion enhance-
ment procedures. Examples ofthe chromatogams of32P-labeled
adducts obtained are shown in Figure 1. All samples exhibited a
complex pattern ofadduct spots and areas ofunresolved radioac-
tivity. There were no readily apparent qualitative differences be-
tween the profiles of DNA adducts from smokers and non-
smokers. A 3- to 5-fold greater recovery ofadducts was obtain-
ed with the butanol extraction method than when nuclease PI
digestion was used. The adduct levels obtained in experiments
using butanol extraction are shown in Figure 2. Among 16 non-
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FIGURE 2. Total adduct levels in hunn bladder DNA samples. Those marked
with a diamond ( * ) were frm patients with a bladder carcinoma or with














FIGURE 3. Levels ofadduct5 (see Fig. 1) in bladder DNA samples. The mean
value for smokers (1.00) was significantly higher (p < 0.005) than the mean
for nonsmokers (0.51).
smokers, adduct levels were in the range 3.2-20.8/108 nu-
cleotides, with a mean value of9.7. Eight ex-smokers had values
in the range 2.6-12.3 (mean 7.1). Thirteen smokers had adduct
levels between 1.3 and 26.7/108 nucleotides (mean 9.5). Thus,
there was no significant increase in levels among cigarette
smokers compared to nonsmokers or ex-smokers. Six cigar
smokers had between 7.3 and 15.0 adducts/108 nucleotides and
showed a higher mean value (12.1), but pipe smokers did not (five
samples, mean 8.6, range 2.9-12.7). No difference was found bet-
ween adduct levels in individuals with bladder carcinoma (past
or present) and levels in patients without tumors.
A further 8 DNA samples from nonsmokers and 17 samples
from smokers were analyzed by 32P-postlabeling in duplicate us-
ing the butanol-extraction enhancement procedure. Similar ad-
duct profiles to those shown in Figure 1 were obtained. No
significant differences were found in overall adduct levels be-
tween smokers (22.7 ± 8.7 adducts/108 nucleotides; range
13.0-32.8) and nonsmokers (17.5 ± 9.8 adducts/108nucleotides;
range 4.1-36.6). The five major adduct spots were individually
quantitated, and comparison of the levels of the individual ad-
ducts 1-4 also revealed no differences between smokers and
nonsmokers. However, adduct 5 (Fig. 1), accounting for be-
tween 2.5 and 6% of the total DNA binding, was 2-fold higher
in smokers than nonsmokers (Fig. 3), and this difference
is statistically significant (Student's t test, one-tailed, p <
0.005).
These results are in close agreement with the recently
published findings of Talaska et al. (9), who detected an adduct,
identified as being derived from 4-aminobiphenyl, at 3- to 4-fold
higher levels in bladder DNA from smokers than from non-
smokers. However, the chromatographic mobility of adduct 5
reported here is different from that ofN-(deoxyguanosin-8-yl)-
4-aminobiphenyl-3 ',5 '-bisphosphate, and its identity has yet to
be determined.
The greater levels ofadducts detected by the butanol extraction
procedure indicate the probable greater contribution to DNA
binding ofaromatic amines relative to the PAHs, since the levels
determined by nuclease P1 digestion may be postulated to approx-
imate the contribution to DNA damage by PAH, whereas the
levels determined by butanol extraction should include adducts
formed both by PAHs and aromatic amines. Thus, these results,
in agreementwith those ofTalaska et al. (9), indicate that the ma-
jority of DNA adducts in human bladder derive from sources
other than tobacco smoke. Nevertheless, the levels ofa relatively
minor adduct are significantly elevated in DNA samples from
smokers.
DNA Adducts in Tissues of the
Respiratory Tract
In contrast to the results obtained with human bladder DNA,
evidence to date suggests that there is a clear association between
cigarette smoking and total levels ofDNA adducts in cells ofthe
human respiratory tract. In a study of DNA isolated from
peripheral lung, a linear correlation was found between daily
cigarette consumption and adduct levels (10). The adduct pat-
terns were characteristic of DNA adducts, and a subsequent
study of DNA from bronchial epithelium confirmed that the
same relationship between adduct levels and smoke intake held
for this tissue also (11). Furthermore, similar levels of adducts
were determined by both the butanol extraction method and by
the nuclease P1 method, suggesting that PAHs are the major con-
tributors to DNA binding, with little or no contribution from
aromatic amines in this tissue. Other parallel or subsequent
studies have arrived at the same conclusion: there is a linear cor-
relation between the levels ofDNA adducts in human bronchus
and peripheral lung and tobacco smoke intake (12-14). In a study
designed to examine a more readily obtainable source ofDNA
from the human respiratory tract, we have also analyzed DNA
from bronchoalveolar lavage cells and have found that adduct
levels are significantly higher in cells from smokers than in cells
from nonsmokers and ex-smokers (15). However, in no study to
date has a correlation between adduct levels and disease status
been noted; that is, adduct levels are not significantly higher in
the respiratory tract oflung cancer patients than in noncancer pa-
tients with the same level of tobacco smoke intake.
DNA Adducts in Circulating Blood Cells
Several "P-postlabeling studies have now been reported in
which elevated levels of DNA adducts have been detected in
blood cells of workers occupationally exposed to PAHs, and











FIGURE 4. Schematic representation of the possibility of multiple routes of intake of carcinogens leading to adducts in tissues that are targets fortumor induction
and in circulating white blood cells used as a readily obtainable surrogate source of DNA.
cancer incidence resulting from the exposure. Published studies
now include data on workers in iron foundries (16), coke ovens
(17), aluminium production (18), and roofers (19). All these
studies clearly indicate exposure-related adducts in circulating
blood cells, but it is interesting to examine the evidence relating
to the influence of tobacco smoking on these adduct levels.
For many of these studies, elevated adduct levels due to smok-
ing were not observed, although in some studies where lym-
phocytes were examined, rather than all white blood cells, a weak
effect could be seen (18). Other studies that used matched groups
of nonoccupationally exposed smokers and nonsmokers were
also negative when whole white blood cells were analyzed (8,11),
but positive in one oftwo studies in which lymphocytes only were
examined (20,21). Analogous studies using methods of analysis
other than 32P_postlabeling also give conflicting results: One
study of coke oven workers using ELISA analysis ofwhite blood
cell DNA found an effect of smoking on adduct levels (22). Also,
smokers with lung cancer were found to have higher adduct levels
than smokers without cancer (23). However, in several other
studies, no effect of smoking on adduct levels in white blood cells
has been observed (17,24-28).
Thus, it would appear that the influence of tobacco smoking
on adduct levels in circulating blood cells is no more than a weak
one. As with the results with bladder DNA, the evidence points
to the involvement of other sources of carcinogens, and whether
or not a significant difference between smokers and nonsmokers
is observed may depend on the strength of influence of these
other factors in the particular populations being studied. Among
occupationally exposed individuals, the occupational source of
carcinogens appears to be the dominating influence in determin-
ing levels ofDNA adducts in blood cells. Among nonoccupa-
tionally exposed individuals, sources of environmental genotoxic
chemicals other than tobacco smoking make a greater contribu-
tion to the total DNA damage in white blood cells, and it is
clearly important that more be learned about the origins of these
adducts. The particular balance of intake ofcarcinogens by inhal-
ation, ingestion, and skin absorption (Fig. 4) will influence the
distribution of adducts in different human tissues, and there is
evidence that PAH-DNA adducts can arise in blood cells as a
result ofdietary intake (29-32). This and the possibility of skin
absorption (33) will complicate attempts to extrapolate data on
adduct levels in blood cells to levels in putative target organs.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers in Human Cancer: Applications in Molecular Epidem-
iology and Risk Assessment that was held in Kailua-Kona, Hawaii, 26 October-I
November 1991.
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